Department of Internal Medicine I, Division of Cardiology, Angiology, and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University Jena, Germany.
Cardiol J. 2021;28(4):579-588. doi: 10.5603/CJ.a2021.0046. Epub 2021 May 4.
Percutaneous tricuspid repair using the edge-to-edge technique is a novel treatment option. More data are needed to better understand which aspects predict a favorable outcome.
Twenty high-risk patients (78.6 ± 8.3 years, EuroScore II 9.1 ± 7.7%, STS score 8.8 ± 4.3) with severe symptomatic tricuspid regurgitation (TR) were treated with the MitraClip® system. All patients underwent standardized pre-, peri-, and post-procedural evaluation. Acute success was defined as successful edge-to-edge repair with TR reduction of ≥ 1 grade and survival until hospital discharge.
Fifteen (75%) patients showed acute success until discharge and 12 (60%) at 30-day followup. In 5 (25%) patients repair failed due to either unsuccessful clip implantation (n = 2), single leaflet device attachment (n = 1), TR reduction < 1 grade (n = 1), or in-hospital death (n = 1). Comparing patients with successful procedure versus those with failed repair revealed similar comorbidities but more severe right heart failure, lower left ventricular ejection fraction, worse renal function, and higher diuretic equivalent doses in the failed repair group. No differences in conventional echocardiographic parameters for TR severity but more dilated tricuspid annulus geometry (tricuspid valve annulus, coaptation depth, tenting area) in the failed repair group were observed. The success rate of non-central/non-anteroseptal jet location was only 25%.
Tricuspid annulus geometry assessment may be of crucial importance and seems to impact procedural outcomes in patients undergoing edge-to-edge tricuspid valve repair. Further investigations including advanced imaging are needed to better understand and treat this complex valve disease.
经皮三尖瓣修复术采用的是瓣对瓣技术,这是一种新颖的治疗选择。需要更多的数据来更好地了解哪些方面可以预测良好的结果。
20 名高危患者(78.6 ± 8.3 岁,EuroScore II 9.1 ± 7.7%,STS 评分 8.8 ± 4.3)患有严重症状性三尖瓣反流(TR),接受 MitraClip®系统治疗。所有患者均接受了标准化的术前、术中和术后评估。急性成功定义为成功的瓣对瓣修复,TR 减少≥1 级,且在出院前存活。
15 名(75%)患者在出院时表现出急性成功,12 名(60%)在 30 天随访时表现出急性成功。在 5 名(25%)患者中,修复失败,原因分别为夹合器植入不成功(n = 2)、单叶器械附着(n = 1)、TR 减少<1 级(n = 1)或院内死亡(n = 1)。比较手术成功患者与修复失败患者,发现两组患者的合并症相似,但修复失败组的右心衰竭更严重,左心室射血分数更低,肾功能更差,利尿剂等效剂量更高。两组患者的 TR 严重程度的常规超声心动图参数无差异,但修复失败组的三尖瓣瓣环几何形状(三尖瓣瓣环、靠拢深度、膨出面积)更大。非中央/非前间隔射流位置的成功率仅为 25%。
三尖瓣瓣环几何形状评估可能至关重要,似乎会影响接受瓣对瓣三尖瓣修复术的患者的手术结果。需要进一步的研究,包括先进的影像学检查,以更好地理解和治疗这种复杂的瓣膜疾病。